Abstract

A unified synthetic strategy accessing novel 3'-fluorinated purine nucleoside derivatives and their biological evaluation were achieved. Novel 3’-fluorinated analogues were constructed from a common 3’-deoxy-3’-fluororibofuranose intermediate. Employing Suzuki and Stille cross-coupling reactions, fifteen 3’-fluororibose purine nucleosides 1–15 and eight 3’-fluororibose 2-chloro/2-aminopurine nucleosides 16–23 with various substituents at position 6 of the purine ring were efficiently synthesized. Furthermore, 3’-fluorine analogs of natural products nebularine and 6-methylpurine riboside were constructed via our convergent synthetic strategy. Synthesized nucleosides were tested against HT116 (colon cancer) and 143B (osteosarcoma cancer) tumor cell lines. We have demonstrated 3’-fluorine purine nucleoside analogues display potent tumor cell growth inhibition activity at sub- or low micromolar concentration.

Highlights

  • Antimetabolites are extremely useful for the treatment of cancers and viral infections and are one of the largest classes of drugs

  • The design of new antimetabolites is an active field of research and several nucleoside derivatives have recently come to market such as gemcitabine, capecitabine, and decitabine [4,5,6]

  • Current strategies to the synthesis of 3’-fluorine and 6-substituted purine require harsh conditions and laborious protecting group manipulation that results in low product yields

Read more

Summary

Introduction

Antimetabolites are extremely useful for the treatment of cancers and viral infections and are one of the largest classes of drugs. Current strategies to the synthesis of 3’-fluorine and 6-substituted purine require harsh conditions and laborious protecting group manipulation that results in low product yields. This key intermediate 25 can be used to synthesize a variety of 3’-fluoro-modified nucleoside derivatives, and it was utilized for the synthesis of all analogues reported .

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call